Teva Pharmaceutical Finance Netherlands II BV

No results found for "".

	PRICED: Teva US2.325bn (US$/EUR) equiv sr notes 3-part	May 20, 2025
	LAUNCH/UPSIZE: Teva US2.325bn (US$/EUR) equiv sr notes 3-part pxg today	May 20, 2025
	RATED: S&P/Fitch rate Teva US$/EUR sr notes BB/BB+	May 20, 2025
	PX TALK: Teva sr notes $500m 5.5NCL 6%a; $500m 7.5NCL +25bp vs 5.5y; E900m 6NCL 4.25-4.50%, pxg today	May 20, 2025
	IPT: Teva E900m 6NCL sr notes mid-high 4s, pxg today	May 20, 2025
	IPT: Teva approx US$500m 5.5NCL low 6s, US$500m 7.5NCL +25bp vs 5.5y tranche	May 19, 2025
	NEW ISSUE: Teva approx $2bn (EUR/US$) sr unsec 3-part on the road	May 19, 2025
	HY TENDER: Teva tender offer for 2023-2026 notes early results, ups tender caps	Mar 14, 2023
	PRICED: Teva $2.49bn (EUR/US$) sr unsec SLB 4-part	Mar 1, 2023
	RVSD TALK/UPSIZE: Teva $2.49bn (EUR/US$) sr unsec SLB 4-part	Mar 1, 2023

1 to 10 of 21

Industry	Status	Date	Ticker(s)	issuer(s)	MO	SP	FI	Size (M)	Ranking	TNR	Call	MTY	Coupon	Leads	product	Region
HLTH	PRCD	Sep 9, 2026	TEVA	Teva Pharmaceutical Finance Netherlands II BV	Baa3	BBB-	BBB-	€1,000	Sr. Unsecured	6.50	-	Mar-33	4.25%	BNP,CTI,...	IGC	EMEA
HLTH	PRCD	Sep 9, 2026	TEVA	Teva Pharmaceutical Finance Netherlands II BV	Baa3	BBB-	BBB-	€500	Sr. Unsecured	10.00	-	Sep-36	4.625%	BNP,CTI,...	IGC	EMEA
HLTH	PRCD	May 20, 2025	TEVA	Teva Pharmaceutical Finance Netherlands II BV	Ba1	BB	BB+	$700	Sr. Unsecured	5.50	0.00	Dec-30	5.750%	BNP,BAM,...	HYC	EMEA
HLTH	PRCD	May 20, 2025	TEVA	Teva Pharmaceutical Finance Netherlands II BV, Teva Pharmaceutical Finance Netherlands III BV	Ba1	BB	BB+	$500	Sr. Unsecured	7.50	0.00	Dec-32	6.000%	BNP,BAM,...	HYC	EMEA
HLTH	PRCD	May 20, 2025	TEVA	Teva Pharmaceutical Finance Netherlands II BV	Ba1	BB	BB+	€1,000	Sr. Unsecured	6.00	0.00	Jun-31	4.125%	BNP,BAM,...	HYC	EMEA
HLTH	PRCD	Mar 1, 2023	TEVA	Teva Pharmaceutical Finance Netherlands II BV	Ba2	BB-	BB-	€800	Sr. Unsecured	6.50	0.00	Sep-29	7.375%	CTI,...	HYC	EMEA
HLTH	PRCD	Mar 1, 2023	TEVA	Teva Pharmaceutical Finance Netherlands II BV	Ba2	BB-	BB-	€500	Sr. Unsecured	8.50	0.00	Sep-31	7.875%	CTI,...	HYC	EMEA
HLTH	PRCD	Mar 1, 2023	TEVA	Teva Pharmaceutical Finance Netherlands II BV	Ba2	BB-	BB-	$600	Sr. Unsecured	6.50	0.00	Sep-29	7.875%	CTI,...	HYC	EMEA
HLTH	PRCD	Mar 1, 2023	TEVA	Teva Pharmaceutical Finance Netherlands II BV	Ba2	BB-	BB-	$500	Sr. Unsecured	8.50	0.00	Sep-31	8.125%	CTI,...	HYC	EMEA
HLTH	PRCD	Nov 2, 2021	TEVA	Teva Pharmaceutical Finance Netherlands II BV	Ba2	BB-	BB-	€1,100	Sr. Unsecured	5.50	0.00	May-27	3.750%	BAM,BNP,...	HYC	EMEA